Product Information
BUMETANIDE 0.5 MG TABLET is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $0.1356 per EA under NDC 00832054011. Its NADAC has been published 435 times since Mar 7, 2018.
FDA first approved this application on Jan 23, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00832054011
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
6/17/2026
Active Ingredients
BUMETANIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209916FDA Approved
1/23/2018
TE Code
AB
On Market Since
1/30/2018
Pharmacological Classes
Price Statistics
The NADAC for BUMETANIDE 0.5 MG TABLET has been published 435 times since Mar 7, 2018, and over the history we have for it it has declined 76.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1356 per EA |
|---|---|
| All-time high | $0.6244 (Sep 11, 2019) |
| All-time low | $0.1213 (May 22, 2024) |
| 52-week high | $0.1617 |
| 52-week low | $0.1265 |
| Median price | $0.2305 |
| Average price | $0.2974 |
| Largest weekly change | +29.3% (Jun 19, 2024) |
| Weeks tracked | 435 |
| Tracking since | Mar 7, 2018 |
1W
N/A
1M
N/A
3M
+1.2%
6M
+7.2%
1Y
-16.1%
3Y
-42.3%
5Y
-55.4%
All
-76.7%
Last surveyed Jul 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the BUMETANIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUMETANIDE 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUMETANIDE 0.5 MG TABLET, manufactured by Upsher-Smith Laboratories LLC, is $0.1356 per EA (NDC 00832054011), effective Jul 1, 2026.
How has the price of BUMETANIDE 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUMETANIDE 0.5 MG TABLET has declined 76.7%. It has been tracked across 435 weekly CMS publications since Mar 7, 2018.
What are the highest and lowest recorded NADAC prices for BUMETANIDE 0.5 MG TABLET?
Since Mar 7, 2018, the NADAC for BUMETANIDE 0.5 MG TABLET has ranged from a low of $0.1213 (May 22, 2024) to a high of $0.6244 (Sep 11, 2019), with a median of $0.2305 per EA.
Are there cheaper alternatives to BUMETANIDE 0.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of BUMETANIDE 0.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BUMETANIDE 0.5 MG TABLET?
BUMETANIDE 0.5 MG TABLET (NDC 00832054011) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.